Zai Lab ZLAB
NASDAQ ZLAB
$26.28 -0.72 (-2.65%)
As of: Sep 4, 2026 · 2:31 PM EDT

Zai Lab (ZLAB) Enterprise Value (2017 - 2026)

Zai Lab (ZLAB) posted Enterprise Value of -$751.3 million for Q1 2026, up 3.62% sequentially from -$779.6 million in Q4 2025, and up 12.36% YoY from -$668.7 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Enterprise Value (2017 - 2026) Analysis & Trends

Zai Lab has reported Enterprise Value for 11 years, with the latest figure at -$751.3 million in Q1 2026.

  • Quarterly Enterprise Value rose 12.36% year-over-year to -$751.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$751.3 million (up 12.36% YoY) and the FY2025 annual result came in at -$779.6 million, changed 0.01% from the prior year.
  • Enterprise Value advanced to -$751.3 million in Q1 2026 per ZLAB's latest filing, from -$779.6 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$716.1 million in Q3 2024 and troughed at -$1.3 billion in Q1 2022.
  • A 5-year average of -$890.7 million and a median of -$820.4 million in 2023 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2022 and 2023: Enterprise Value decreased 29.49% in 2022, then soared 30.37% in 2023.
  • Over 5 years, Enterprise Value stood at -$1.0 billion in 2022, then advanced by 20.03% to -$806.5 million in 2023, then climbed by 3.32% to -$779.7 million in 2024, then rose by 0.01% to -$779.6 million in 2025, then climbed by 3.62% to -$751.3 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$751.3 million, -$779.6 million, and -$817.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Zai Lab 2.93 Bn 2.22 Bn 58.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.43 Bn
Mar 31, 2026 1.34 Bn
Dec 31, 2025 1.17 Bn
Sep 30, 2025 2.93 Bn
Jun 30, 2025 3.01 Bn
Mar 31, 2025 3.06 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 1.66 Bn
Jun 30, 2024 970.71 Mn
Mar 31, 2024 808.42 Mn
Dec 31, 2023 1.85 Bn
Sep 30, 2023 1.54 Bn
Jun 30, 2023 1.81 Bn
Mar 31, 2023 2.27 Bn
Dec 31, 2022 1.94 Bn
Sep 30, 2022 2.16 Bn
Jun 30, 2022 2.07 Bn
Mar 31, 2022 2.90 Bn
Dec 31, 2021 4.59 Bn
Sep 30, 2021 8.47 Bn